Following the ERS International Congress, we were delighted to catch up with Prof. Ivan Gentile to further discuss the topic of his presentation entitled ‘Severity Assessment and Outcome Prediction in COVID-19 Patients‘.
Questions
1. Why do levels of C-reactive protein (CRP) increase during COVID-19? (0:20)
2. How can CRP testing inform severity assessment and outcome prediction in the early stages of COVID-19? (0:58)
3. At what stages of the illness is CRP testing most useful? (1:40)
4. What are the remaining gaps in our knowledge and what further studies are planned? (3:07)
Speaker disclosure: Ivan Gentile has acted as a consultant for Abbvie, Gilead, MSD, Pfizer, Nordic, Correvio, Angelini and Abbott.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress 2020.
